Chunlin Jin
Overview
Explore the profile of Chunlin Jin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu L, Tang Z, Hu J, Li D, Zhang A, Chen Y, et al.
BMJ Paediatr Open
. 2025 Mar;
9(1).
PMID: 40050024
Background: X-linked hypophosphataemia (XLH) is a rare inherited disorder often misdiagnosed and lacking sufficient aetiological treatment. Previous studies have shown that XLH is associated with worse health-related quality of life...
2.
Xing Q, Cheng W, Wang W, Jin C, Wang H
Front Pharmacol
. 2025 Feb;
16:1474856.
PMID: 39911851
Objectives: Paying for the innovative value of drugs is an important means of mitigating healthcare system duplication and enhancing patient health. Assessing and exploiting the factors influencing innovation premium to...
3.
He A, Chen M, Song P, Wu Q, Jin C, He J
Intractable Rare Dis Res
. 2024 Dec;
13(4):203-207.
PMID: 39628624
The pathogenesis of diseases in the field of rare diseases is complex. Many rare diseases have yet to be conquered worldwide, and there are still no effective treatments for most...
4.
Song J, Guo W, Jin C, Xu Y, Hu X, Zhang Z, et al.
BMJ Open
. 2024 Dec;
14(12):e088318.
PMID: 39627122
Objectives: To analyse the impacts of multiple rounds of National Centralised Drug Procurement Policy (NCDP) and National Drug Price Negotiation Policy (NDPN) on the utilisation, expenditure and daily cost of...
5.
Kang Q, Fang Y, Yang Y, Li D, Zheng L, Chen X, et al.
Orphanet J Rare Dis
. 2024 Sep;
19(1):324.
PMID: 39243096
Background: Patients with mucopolysaccharidosis (MPS) often face delayed diagnoses, limited treatment options and high healthcare costs, that may significantly affect patients' quality of life. The objective of this study was...
6.
Gu Y, Liu M, Wang A, He D, Sun H, Cui X, et al.
Value Health Reg Issues
. 2024 Aug;
44:101029.
PMID: 39094426
Objectives: This study analyzed the basic condition and the influencing factors of hospitalization costs of patients with gastric cancer in Shanghai from 2014 to 2021, so as to provide a...
7.
Wang H, Sun H, Fu Y, Cheng W, Jin C, Shi H, et al.
BMC Health Serv Res
. 2024 Mar;
24(1):397.
PMID: 38553709
Importance: Innovative nuclear medicine services offer substantial clinical value to patients. However, these advancements often come with high costs. Traditional payment strategies do not incentivize medical institutes to provide new...
8.
Tang M, Yang Y, Ye Z, Song P, Jin C, Kang Q, et al.
Intractable Rare Dis Res
. 2023 Nov;
12(4):251-256.
PMID: 38024584
On September 18, 2023, the National Health Commission of China officially announced the "Second List of Rare Diseases". This list of 86 rare diseases, drafted in accordance with the "Working...
9.
Li R, Liu M, Song J, Xu Y, He A, Hu X, et al.
Environ Res
. 2023 Sep;
238(Pt 2):117155.
PMID: 37775008
Background: Living near and enjoying visually green landscapes is associated with better mental health, but evidence focusing on vulnerable populations (such as cancer survivors) is sparse. The purpose of this...
10.
Song J, Li R, Hu X, Ding G, Chen M, Jin C
Glob Health Med
. 2023 Sep;
5(4):208-215.
PMID: 37655186
Cancer is currently a major public health issue faced by countries around the world. With the progress of medical science and technology, the survival rate of cancer patients has increased...